C1QL2: A Drug Target / Disease Biomarker (G165257)

Target Name: C1QL2

NCBI ID: G165257

C1QL2

C1QL2: A Drug Target / Disease Biomarker

C1QL2 is a protein that is expressed in various tissues throughout the body. It is a member of the C1Q family of proteins, which are known for their role in cell signaling and inflammation. C1QL2 has been identified as a potential drug target or biomarker, and research is being conducted to investigate its potential utility as a therapeutic agent.

C1QL2 is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and blood vessels. It is a member of the C1Q family of proteins, which are known for their role in cell signaling and inflammation. The C1Q family includes a number of different proteins, including C1Q1, C1Q2, C1Q3, and C1Q4. These proteins are characterized by the presence of a unique N-terminal domain that is composed of a combination of amino acids.

One of the defining features of C1QL2 is its role in cell signaling. C1QL2 is a member of the T-cell receptor (TCR) signaling pathway, which is a critical pathway that is involved in the regulation of immune responses. C1QL2 is thought to play a role in the regulation of T-cell proliferation and differentiation, as well as in the regulation of immune cell function.

C1QL2 is also involved in the regulation of inflammation. In response to the release of pro-inflammatory cytokines, C1QL2 is thought to play a role in the regulation of the NF-kappa-B signaling pathway, which is a critical pathway that is involved in the regulation of inflammation. C1QL2 is also thought to play a role in the regulation of the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾.

C1QL2 is also involved in the regulation of cell adhesion. C1QL2 is a member of the cadherin family of proteins, which are known for their role in cell adhesion. C1QL2 is thought to play a role in the regulation of cadherin-based adhesion, as well as in the regulation of tight junction formation.

In addition to its role in cell signaling and inflammation, C1QL2 is also thought to have a number of potential therapeutic applications. For example, C1QL2 has been shown to be a potential drug target, with research being conducted to investigate its potential utility as a therapeutic agent for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the challenges in the study of C1QL2 is its relatively high complexity. C1QL2 is a member of the C1Q family of proteins, which are known for their complex structure and function. As a result, the study of C1QL2 is likely to require a combination of techniques, including biochemical, cellular, and mass spectrometry-based approaches, to fully understand its role in cell signaling and inflammation.

In conclusion, C1QL2 is a protein that is expressed in various tissues throughout the body and is involved in a number of critical processes in cell signaling and inflammation. As a result, C1QL2 is a potential drug target or biomarker with a number of potential therapeutic applications. Further research is needed to fully understand its role in cell signaling and inflammation and to develop effective therapies based on its properties.

Protein Name: Complement C1q Like 2

Functions: May regulate the number of excitatory synapses that are formed on hippocampus neurons. Has no effect on inhibitory synapses (By similarity)

The "C1QL2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1QL2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets